Biomedix Incubator Cash Flow From Operations vs. Cash And Equivalents
| BMDX Stock | ILS 19,760 490.00 2.54% |
For Biomedix Incubator profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biomedix Incubator to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biomedix Incubator utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biomedix Incubator's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biomedix Incubator over time as well as its relative position and ranking within its peers.
Biomedix |
Biomedix Incubator Cash And Equivalents vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biomedix Incubator's current stock value. Our valuation model uses many indicators to compare Biomedix Incubator value to that of its competitors to determine the firm's financial worth. Biomedix Incubator is rated below average in cash flow from operations category among its peers. It also is rated below average in cash and equivalents category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomedix Incubator by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomedix Incubator's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biomedix Cash And Equivalents vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Biomedix Incubator |
| = | (1.62 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Biomedix Incubator |
| = | 5.71 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Biomedix Cash And Equivalents Comparison
Biomedix Incubator is currently under evaluation in cash and equivalents category among its peers.
Biomedix Incubator Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biomedix Incubator, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biomedix Incubator will eventually generate negative long term returns. The profitability progress is the general direction of Biomedix Incubator's change in net profit over the period of time. It can combine multiple indicators of Biomedix Incubator, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York. Biomedix Incubator is traded on Tel Aviv Stock Exchange in Israel.
Biomedix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biomedix Incubator. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biomedix Incubator position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biomedix Incubator's important profitability drivers and their relationship over time.
Use Biomedix Incubator in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomedix Incubator position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomedix Incubator will appreciate offsetting losses from the drop in the long position's value.Biomedix Incubator Pair Trading
Biomedix Incubator Pair Trading Analysis
The ability to find closely correlated positions to Biomedix Incubator could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomedix Incubator when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomedix Incubator - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomedix Incubator to buy it.
The correlation of Biomedix Incubator is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomedix Incubator moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomedix Incubator moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomedix Incubator can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biomedix Incubator position
In addition to having Biomedix Incubator in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Staples ETFs Thematic Idea Now
Consumer Staples ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biomedix Stock
To fully project Biomedix Incubator's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biomedix Incubator at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biomedix Incubator's income statement, its balance sheet, and the statement of cash flows.